In ALL, some approaches have been oriented towards analyzing the targeting of transcriptional factors such as PAX5, which are involved in the pathogenesis of B-ALL, and TAL1 and LMO2, which are highly deregulated in T-ALL [3–5]. This evidence concerns the gene PAX5 and acute lymphoblastic leukemia.